Post Reply
181-193 of 193
load up before it zipped past 40 cents after dual listing approval news is announced.
cah should rally today. wondering why not.
look out for tomorrow trading. dual listing news in hk is close to be announced. the potential is too big to be ignored.
Hi fellow forumers,
FYI, here are the following analyst target prices for CAL post its 3QFY10 results
Amfraser: Hold - $0.34
DMG: Buy - $0.48
CIMB: Buy - $0.52
Kim Eng: Buy - $0.48
Have a gd weekend.
crclk15 ( Date: 14-Oct-2010 17:27) Posted:
|
good price to load now. dual listing coming soon. once approved, it will zoom pass 40 cents per the agreement between cah and blackstone. very powerful stock with huge potential
Loaded!
the only stock with 3 fund houses staking an interest in it and recently increased their stakes. whats more to say?
load up before you are left out
China Animal Healthcare (CAL SP, $0.355, BUY, TP $0.48) – We initiate coverage on China Animal Healthcare with a BUY recommendation and target price of $0.48/share, pegged at 15x FY11F PER, a discount to its peer average of 23x. While FY10 net profit may be hurt by certain one-off expenses, we remain confident about the group’s longer-term growth prospects given its leading market position in animal drug manufacturing and distribution
/KIM ENG
China Animal Q3-2010 net profit falls sharply by 59.6% due to one off exceptional items
Although China Animal's Q3-2010 results were
disppointing on the surface - they look okay if we add back two one off
exceptional charges linked to new staff share options and expenses linked to its
HK dual listing.
The core business continues to grow as evidenced by the
revenue and gross profit growth and is likely to continue into 2011 with new
Government contracts as well as new acquisitions.
Have to pay more for food next year and to eat less.
enghou ( Date: 11-Nov-2010 15:29) Posted:
|
I am expecting food prices will increase a lot in 2011 and this company can benefit from this trend.
Make love more, don't make more enemies
pull back will not be much. at most a bid only.
china animal and c&o pharma are gem stocks. it will grow double easily next year. both have monopoly of medicines in their own specialized fields which has high margins and the industry is growing.
load up before you are left out
Everything seems rosy on China Animal Healthcare. I prefer to wait for a pull back.
http://mystocksinvesting.com/singapore-stocks/china-animal-health/china-animal-health-wait-for-pull-back/
China Animal seems attractive due mainly to
a) Pro Govt policies and strong domestic economy;
b) Biological drugs (i.e. vaccines) to power growth;
c) Execution risks have abated;
d) Earnings visibility have improved;
e) Blackstone - strong testament to CAL fundamentals;
f) Interest from other institution & insider;
g) Dual listing likely to be end Nov.
Risks:
a) Dual listing not a done deal yet;
b) Diseases which affect poultry or livestock ironically have a negative short term impact on CAL
Readers can take a look at my blog http://ernestlim15.blogspot.com/2010_09_01_archive.html for more details on CAL.